Remedy Pharmaceuticals Secures $500,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5914b6db-fca1-476f-801b-6be6985a6206&Preview=1 - Date
11/22/2011 - Company Name
Remedy Pharmaceuticals - Mailing Address
Undisclosed New York, NY 10001 - Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury. - Website
http://www.remedypharmaceuticals.com - Transaction Type
Venture Equity - Transaction Amount
$500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended. - M&A Terms
- Venture Investor
Undisclosed
